Association between metabolic syndrome and cancer

M Uzunlulu, O Telci Caklili, A Oguz - Annals of Nutrition and Metabolism, 2016 - karger.com
Growing data show the association of metabolic syndrome (MetS) or its components with
cancer development and cancer-related mortality. It is suggested that in MetS and cancer …

The tumor microenvironment and its contribution to tumor evolution toward metastasis

G Lorusso, C Rüegg - Histochemistry and cell biology, 2008 - Springer
Cancer cells acquire cell-autonomous capacities to undergo limitless proliferation and
survival through the activation of oncogenes and inactivation of tumor suppressor genes …

IL‐1β mediated up‐regulation of HIF‐lα via an NFkB/COX‐2 pathway identifies HIF‐1 as a critical link between inflammation and oncogenesis

YJ Jung, JS Isaacs, S Lee, J Trepel… - The FASEB …, 2003 - Wiley Online Library
Growing evidence indicates that inflammation is a contributing factor leading to cancer
development. However, pathways involved in this progression are not well understood. To …

Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment

X Peng, Z Sun, P Kuang, J Chen - European Journal of Medicinal Chemistry, 2020 - Elsevier
Histone deacetylases (HDACs) are a class of enzymes that remove acetyl from the ε-N-
acetyl lysine of histones, allowing histones to wrap DNA more tightly. HDACs play an …

[HTML][HTML] Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement

S Li, M Jiang, L Wang, S Yu - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Chemotherapy with a single chemotherapeutic agent or a combined chemotherapeutic
regimen is the clinically standardized treatment for almost all human cancers. Upregulated …

Regulation of inflammation in cancer by dietary eicosanoids

H Yang, E Rothenberger, T Zhao, W Fan, A Kelly… - Pharmacology & …, 2023 - Elsevier
Background Cancer is a major burden of disease worldwide and increasing evidence shows
that inflammation contributes to cancer development and progression. Eicosanoids are …

Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer

HM Hesham, DS Lasheen… - Medicinal Research …, 2018 - Wiley Online Library
Recently, molecular hybridization paradigm became an interesting and smart way to defeat
the multifaceted cancer disease by a single molecular entity that acts via several …

Epigallocatechin-3-gallate therapeutic potential in cancer: mechanism of action and clinical implications

M Kciuk, M Alam, N Ali, S Rashid, P Głowacka… - Molecules, 2023 - mdpi.com
Cellular signaling pathways involved in the maintenance of the equilibrium between cell
proliferation and apoptosis have emerged as rational targets that can be exploited in the …

Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in …

K Rosenquist, J Wennerberg, EB Schildt… - Acta oto …, 2005 - Taylor & Francis
Conclusion. Our results show that average and poor oral hygiene and inadequate dental
status are independent risk factors for oral and oropharyngeal squamous cell carcinoma …

[HTML][HTML] Squamous cell carcinoma–similarities and differences among anatomical sites

W Yan, II Wistuba, MR Emmert-Buck… - American journal of …, 2011 - ncbi.nlm.nih.gov
Squamous cell carcinoma (SCC) is an epithelial malignancy involving many anatomical
sites and is the most common cancer capable of metastatic spread. Development of early …